NCT05270967View on ClinicalTrials.gov

FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

January 10, 2022

Study Completion Date

January 10, 2022

Conditions
Vaccine ReactionOncology
Interventions
DIAGNOSTIC_TEST

F-18 FDG PET/CT imaging

Oncological imaging

BIOLOGICAL

Pfizer/biontech mRNA vaccine

COVID-19 vaccine

Trial Locations (1)

tr-41650

Kocaeli University School of Medicine Dep. of Nuclear Medicine, Kocaeli

All Listed Sponsors
lead

Kocaeli University

OTHER

NCT05270967 - FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination | Biotech Hunter | Biotech Hunter